Skip to main content
Log in

Risk of osteoporosis in men with chronic bronchitis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Theoretically, patients with chronic bronchitis are at risk for osteoporosis. Bone metabolism was assessed in 44 male chronic bronchitics treated with oral prednisolone (C+;n=19) or with bronchodilatory drugs alone (C−;n=25). In both groups, serum osteocalcin was lower (p<0.001) than in age- and sex-matched controls (mean (ng/ml) C+ 1.0, C− 1.9, controls 4.2), while testosterone was at the lower limit of the reference range. Low trabecular bone mineral density (BMD) was noted in the C− group (median Z score −1.0), but both cortical and trabecular BMD were depressed in the C+ group (−1.0 and −1.4, respectively). In conclusion, chronic bronchitics treated with corticosteroids, even at low doses, are at risk for osteoporosis. In both groups, additional factors such as hypogonadism might be responsible for low BMD and low osteocalcin levels. A decrease in bone formation is a possible mechanism of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma and airflow obstruction: 25 years from the Ciba symposium. Thorax 1984;39:81–5.

    Google Scholar 

  2. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparisons with rhumatoid arthritis and polymyalgia rheumatica. Br Med J 1986;293:1463–6.

    Google Scholar 

  3. Rüegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983;25:615–20.

    Google Scholar 

  4. Adinoff AD, Hollister JR, Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265–8.

    Google Scholar 

  5. Riancho JA, Gonzales MJ, Del-Arco C, Amado JA, Freijanes J, Anton MA. Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 1987;42:962–6.

    Google Scholar 

  6. Krolner B, Toft B, Nielsen ST, Tondevold E. Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial. Clin Sci 1983;64:541–6.

    Google Scholar 

  7. Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977–83.

    Google Scholar 

  8. Raisz LG, Smith J. Osteoporosis. In: Martin TJ, Raisz LG, editors. Clinical endocrinology of calcium metabolism. New York: Marcel Dekker, 1987:201–49.

    Google Scholar 

  9. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989;30:83–103.

    Google Scholar 

  10. Peretz A, Praet JP, Rozenberg S, Bosson D, Famaey JP, Bourdoux P. Osteocalcin and bone mineral content in rheumatoid arthritis. Clin Rheumatol 1989;8:42–8.

    Google Scholar 

  11. Rozenberg S, Ham H, Bosson D, Peretz A, Robyn C. Biological profiles of patients with discordances between cortical and trabecular bone mineral contents. Med Sci Res 1987;15:1097–9.

    Google Scholar 

  12. Geusens P, Dequecker J, Verstraeten A, Nijs J. Age-, sex-, and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med 1986;27:1540–9.

    Google Scholar 

  13. Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K. Risk factor for postmenopausal osteoporosis. Am J Med 1985;78:95–100.

    Google Scholar 

  14. Dunlap NE, Fulmer JD. Corticosteroid therapy in asthma. Clin Chest Med 1984;5:669–83.

    Google Scholar 

  15. Bremner WJ, Vitiello V, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278–81.

    Google Scholar 

  16. Parker LW, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985;60:947–52.

    Google Scholar 

  17. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. L'ostéocalcine (ou GLA-protéine osseuse), nouveau marqueur biologique pour 1'étude de la pathologie osseuse. Presse Med 1986;15:643–6.

    Google Scholar 

  18. Kotowicz MA, Hall S, Hunder GG, Cedel SL, Mann KG, Riggs BL. Relationship of glucocorticoid dosage to serum bone GLA-protein concentrations in patients with rheumatological disorders. Arthritis Rheum 1990;33:1487–92.

    Google Scholar 

  19. Delmas PD, Malaval L, Arlot ME, Meunier PJ. Serum bone GLA-protein compared to bone histomorphometry in endocrine diseases. Bone 1985;6:339–44.

    Google Scholar 

  20. Peretz A, Praet JP, Bosson D, Rozenberg S, Bourdoux P. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis: effect of long and short term corticosteroid treatment. J Rheumatol 1989;16:363–7.

    Google Scholar 

  21. Weissman MH, Orth RW, Catherwood BD, Manolagas SC, Deftos LJ. Measures of bone loss in rheumatoid arthritis. Arch Intern Med 1986;146:701–4.

    Google Scholar 

  22. Delmas PD, Christiaensen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5–11.

    Google Scholar 

  23. Reid IR, Chapman GE, Fraser TRC, Davies AD, Surus AS, Meyer J, et al. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 1986; 62:379–83.

    Google Scholar 

  24. Gundberg CM, Lian JB, Gallop PM. Measurements of gammacarboxyglutamate and circulating osteocalcin in normal children and adults. Clin Chim Acta 1983;128:1–8.

    Google Scholar 

  25. Beresford JN, Gallagher JA, Poser JW, Russell RGG. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone and glucocorticoids. Metab Bone Dis Rel Res 1984;5:229–34.

    Google Scholar 

  26. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone, Calcif Tissue Int 1986;38:60–1.

    Google Scholar 

  27. Evans DB, Russell RGG, Brown BL, Dobson PRM. Agents affecting adenylate cyclase activity modulate the stimulatory action of 1,25-dihydroxyvitamin D3 on the production of osteocalcin by human bone cells. Biochem Biophys Res Commun 1989;164:1076–85.

    Google Scholar 

  28. Vernillo AT, Rifkin BR, Hauschka PV. 5,5-Diphenylhydantoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture [abstract]. J Bone Miner Res 1989;4Suppl 1:128.

    Google Scholar 

  29. Nishiyama S, Tomoda S, Ohata T, Higuchi A, Matsuda I. Differences in basal and postexercise osteocalcin levels in athletic and nonathletic human. Calcif Tissue Int 1988;43:150–4.

    Google Scholar 

  30. Bell NH, Godsen RN, Henry DP, Shary J, Epstein S. The effect of muscle-building exercise on vitamin D and mineral metabolism. J Bone Mineral Res 1988;3:369–73.

    Google Scholar 

  31. Henning KN, Kim B, Seif M. Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits. Calcif Tissue Int 1990;47:284–90.

    Google Scholar 

  32. Rijs B, Krabbe S, Christiansen C, Catherwood BD, Deftos LJ. Bone turnover in male puberty: a longitudinal study. Calcif Tissue Int 1985;37:213–17.

    Google Scholar 

  33. Hajiroussou VJ, Webley M. Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis 1984;43:24–7.

    Google Scholar 

  34. Daniell HW. Osteoporosis of the slender smoker. Arch Intern Med 1976;136:298–304.

    Google Scholar 

  35. Khaw KT, Tzuke S, Barret-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988;318:1705–9.

    Google Scholar 

  36. Klaiber EL, Broverman DM, Dalen JE. Serum estradiol levels in male cigarette smokers. Am J Med 1984;77:858–62.

    Google Scholar 

  37. Rambaut PC, Johnston RS. Prolonged weightlessness and calcium loss in man. Acta Astronaut 1979;6:1113–7.

    Google Scholar 

  38. Fortenbery EJ, McDermott MT, Duncan WE. Effect of theophylline on calcium metabolism and circulating vitamin D metabolites. J Bone Miner Res 1990;5:321–4.

    Google Scholar 

  39. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987;65:53–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Praet, J.P., Peretz, A., Rozenberg, S. et al. Risk of osteoporosis in men with chronic bronchitis. Osteoporosis Int 2, 257–261 (1992). https://doi.org/10.1007/BF01624152

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01624152

Keywords

Navigation